Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ARQT
Stock Latest News
Company Announcements
Arcutis Biotherapeutics Completes Promising Psoriasis Treatment Study
2d ago
ARQT
Premium
The Fly
Arcutis Biotherapeutics assumed with an Overweight at Morgan Stanley
16d ago
ARQT
Premium
The Fly
Arcutis announces ZORYVE cream receives strong recommendation from AAD
23d ago
ARQT
Premium
Company Announcements
Arcutis Biotherapeutics Approves Key Proposals at Annual Meeting
1M ago
8K
ARQT
Premium
The Fly
Arcutis Biotherapeutics enrolls first child in INTEGUMENT-INFANT
1M ago
ARQT
Premium
The Fly
Arcutis Biotherapeutics presents new long-term results of ZORYVE cream
1M ago
ARQT
Premium
Ratings
Buy Rating for Arcutis Biotherapeutics Driven by FDA Approval and Market Potential of Zoryve Foam
2M ago
ARQT
Premium
Ratings
Arcutis Biotherapeutics: Buy Rating Affirmed on FDA Approval and Promising Commercial Prospects for Zoryve Foam
2M ago
ARQT
Premium
Ratings
Arcutis Biotherapeutics: Buy Rating Affirmed on Strong FDA Approvals and Promising Pipeline
2M ago
ARQT
Premium
The Fly
Arcutis Biotherapeutics reports FDA approves sNDA for Zoryve topical foam
2M ago
ARQT
Premium
The Fly
Arcutis announces publication of Genital Psoriasis Wellness Consortium statement
2M ago
ARQT
Premium
Ratings
Buy Rating for Arcutis Biotherapeutics: Long-term Growth Potential and Upcoming Catalysts
2M ago
ARQT
Premium
Company Announcements
Arcutis Biotherapeutics Reports Strong Q1 Earnings Growth
2M ago
ARQT
Premium
The Fly
Arcutis Biotherapeutics: Zoryve foam treatment resulted in major improvements
2M ago
ARQT
Premium
Ratings
Arcutis Biotherapeutics: Strong Growth Prospects and Financial Stability Justify Buy Rating
2M ago
ARQT
Premium
Ratings
Arcutis Biotherapeutics: Promising Growth Driven by Zoryve’s Market Expansion and Strategic Approvals
2M ago
ARQT
Premium
Company Announcements
Arcutis Biotherapeutics Reports Strong Q1 2025 Growth
2M ago
ARQT
Premium
The Fly
Arcutis Biotherapeutics reports Q1 EPS (20c), consensus (21c)
2M ago
ARQT
Premium
Ratings
Buy Rating Justified for Arcutis Biotherapeutics Amid Strategic Shifts and Market Potential of Zoryve
2M ago
ARQT
Premium
Pre-Earnings
ARQT Earnings this Week: How Will it Perform?
3M ago
ARQT
Premium
Ratings
Arcutis Biotherapeutics: Buy Rating Affirmed Amid Positive Long-Term Outlook and Strategic Growth Potential
3M ago
ARQT
Premium
Ratings
Positive Outlook for Arcutis Biotherapeutics: Buy Rating Affirmed by Vikram Purohit
3M ago
ARQT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
